Does guided selection of P2Y12-inhibiting therapy improve the balance between safety and efficacy compared to potent P2Y12 inhibitor therapy in patients with acute coronary syndrome?
61,898 patients with acute coronary syndrome (pooled from 15 randomized trials)
Guided selection of P2Y12-inhibiting therapy
Potent P2Y12 inhibitor therapy
Guided selection of P2Y12-inhibiting therapy offers the most favorable balance of safety and efficacy in patients with acute coronary syndrome, supporting its broader adoption.
A guided selection of P2Y12-inhibiting therapy represents the strategy associated with the most favourable balance between safety and efficacy. These findings support a broader adoption of guided P2Y12 inhibiting therapy in patients with acute coronary syndrome.
Building similarity graph...
Analyzing shared references across papers
Loading...
Mattía Galli
Interventional Cardiology
Stefano Benenati
Interventional Cardiology
Francesco Franchi
Interventional Cardiology
European Heart Journal
Harvard University
Yale University
Brigham and Women's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Galli et al. (Mon,) studied this question.
synapsesocial.com/papers/69a303c214f6f437bd907d68 — DOI: https://doi.org/10.1093/eurheartj/ehab836
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: